CRESCENT BIOPHARMA INC.
Q1 2026 13F Holders
Symbol
CBIO
CUSIP
38000Q201
Type
Equity
Class
COM
Num filings
3
Total reported value, excl. options
$15.4 M
Compare 2026 Q1 to
2026 Q2
2025 Q4
Manager
Report Date
Value ($000)
Shares
Option Type